Shandong Jincheng Pharmaceutical Group Co., Ltd (SHE:300233)
China flag China · Delayed Price · Currency is CNY
15.12
-0.17 (-1.11%)
At close: Feb 13, 2026

SHE:300233 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
5,7354,5526,3368,74111,1677,390
Market Cap Growth
20.10%-28.16%-27.51%-21.73%51.12%-4.55%
Enterprise Value
5,4424,2695,9498,63810,9166,954
Last Close Price
15.1211.7015.9321.6127.4117.80
PE Ratio
76.5223.1336.2731.98103.41-
Forward PE
-24.2424.2424.2424.2417.09
PS Ratio
2.061.351.792.493.562.50
PB Ratio
1.541.191.682.393.252.13
P/TBV Ratio
1.831.402.002.773.792.51
P/FCF Ratio
32.8829.5619.73-182.9427.00
P/OCF Ratio
20.5315.359.5434.1925.5413.53
EV/Sales Ratio
1.951.261.682.463.482.35
EV/EBITDA Ratio
11.867.3311.3213.8324.6312.63
EV/EBIT Ratio
41.5516.0927.0523.1448.7419.72
EV/FCF Ratio
31.2027.7218.52-178.8225.41
Debt / Equity Ratio
0.100.140.150.180.190.12
Debt / EBITDA Ratio
0.830.881.051.031.460.74
Debt / FCF Ratio
2.183.351.73-10.691.50
Net Debt / Equity Ratio
-0.10-0.10-0.12-0.06-0.10-0.19
Net Debt / EBITDA Ratio
-0.79-0.69-0.90-0.33-0.74-1.21
Net Debt / FCF Ratio
-2.07-2.61-1.461.76-5.38-2.43
Asset Turnover
0.520.590.600.630.610.56
Inventory Turnover
3.183.763.843.984.574.76
Quick Ratio
1.221.321.140.981.181.63
Current Ratio
1.751.841.481.361.511.93
Return on Equity (ROE)
2.12%5.46%5.20%8.05%3.56%-12.73%
Return on Assets (ROA)
1.52%2.88%2.34%4.20%2.73%4.16%
Return on Invested Capital (ROIC)
2.52%6.09%5.58%9.40%4.75%10.82%
Return on Capital Employed (ROCE)
3.20%6.10%5.10%9.10%5.80%9.20%
Earnings Yield
1.35%4.32%2.76%3.13%0.97%-6.62%
FCF Yield
3.04%3.38%5.07%-1.35%0.55%3.70%
Dividend Yield
1.98%2.14%1.26%0.69%0.72%1.13%
Payout Ratio
202.44%66.91%47.80%38.33%97.41%-
Buyback Yield / Dilution
-3.16%2.53%-0.84%0.17%0.60%0.76%
Total Shareholder Return
-1.20%4.67%0.42%0.86%1.32%1.89%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.